Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts

Clinical Oral Investigations

Volumn 16, Issue 4, 2012, Pages 1153-1159

  Ohe, Joo Young ^a   Kwon, Yong Dae ^a   Lee, Hyeon Woo ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Bisphosphonates(BPs); BMSC; BPONJ; M CSF; OPG

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; COLONY STIMULATING FACTOR 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); OSTEOPROTEGERIN; PAMIDRONIC ACID;

ADULT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CULTURE MEDIUM; CULTURE TECHNIQUE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; JAW OSTEONECROSIS; MALE; MESENCHYMAL STROMA CELL; OSTEOBLAST; OSTEOCLAST; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TIME;

ALENDRONATE; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CULTURE MEDIA; DIPHOSPHONATES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPROTEGERIN; REAL-TIME POLYMERASE CHAIN REACTION; TIME FACTORS; YOUNG ADULT;

EID: 84864281419     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-011-0614-z     Document Type: Article

References (28)

1. Allen MR, Burr DB (2009) The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 67: 61-70. doi: 10. 1016/j. joms. 2009. 01. 007.
2. Kyrgidis A, Vahtsevanos K (2009) "Fatigue" having a role in the pathogenesis of osteonecrosis of the jaws. Clin Oral Investig 13: 479-480; author reply 483-474. doi: 10. 1007/s00784-009-0319-8.
3. Hoefert S, Schmitz I, Tannapfel A, Eufinger H (2009) Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin Oral Investig 14: 271-284. doi: 10. 1007/s00784-009-0300-6.
4. Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63: 1567-1575. doi: 10. 1016/j. joms. 2005. 07. 010.
5. Bertoldo F, Santini D, Lo Cascio V (2007) Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle. Nat Clin Pract Oncol 4: 711-721. doi: 10. 1038/ncponc1000.
6. Ziebart T, Pabst A, Klein MO, Kammerer P, Gauss L, Brullmann D, Al-Nawas B, Walter C (2011) Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro. Clin Oral Investig 15: 105-111. doi: 10. 1007/s00784-009-0365-2.
7. Pabst AM, Ziebart T, Koch FP, Taylor KY, Al-Nawas B, Walter C (2011) The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes-in vitro study. Clin Oral Investig. doi: 10. 1007/s00784-010-0507-6.
8. Simon MJ, Niehoff P, Kimmig B, Wiltfang J, Acil Y (2010) Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clin Oral Investig 14: 51-58. doi: 10. 1007/s00784-009-0312-2.
9. Benford HL, McGowan NW, Helfrich MH, Nuttall ME, Rogers MJ (2001) Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 28: 465-473.
10. Rogers MJ, Chilton KM, Coxon FP, Lawry J, Smith MO, Suri S, Russell RG (1996) Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism. J Bone Miner Res 11: 1482-1491.
11. Boonekamp PM, van der Wee-Pals LJ, van Wijk-van Lennep MM, Thesing CW, Bijvoet OL (1986) Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner 1: 27-39.
12. Rodan GA, Reszka AA (2002) Bisphosphonate mechanism of action. Curr Mol Med 2: 571-577.
13. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA (1991) Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88: 2095-2105. doi: 10. 1172/JCI115539.
14. Kim TW, Yoshida Y, Yokoya K, Sasaki T (1999) An ultrastructural study of the effects of bisphosphonate administration on osteoclastic bone resorption during relapse of experimentally moved rat molars. Am J Orthod Dentofacial Orthop 115: 645-653.
15. Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13: 581-589. doi: 10. 1359/jbmr. 1998. 13. 4. 581.
16. Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, Wesolowski G, Russell RG, Rodan GA, Reszka AA (1999) Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A 96: 133-138.
17. Coxon FP, Helfrich MH, Van't Hof R, Sebti S, Ralston SH, Hamilton A, Rogers MJ (2000) Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res 15: 1467-1476. doi: 10. 1359/jbmr. 2000. 15. 8. 1467.
18. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, van Poznak CH, Watts N, Woo SB, Shane E (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22: 1479-1491. doi: 10. 1359/jbmr. 0707ONJ.
19. Aubin JE, Triffitt JT (2002) Mesenchymal stem cells and the osteoblast lineage. In Principles of Bone Biology, 2nd edn. Academic, New York, NY.
20. Lagasse E, Weissman IL (1997) Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89: 1021-1031.
21. Bai S, Kopan R, Zou W, Hilton MJ, Ong CT, Long F, Ross FP, Teitelbaum SL (2008) NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J Biol Chem 283: 6509-6518. doi: 10. 1074/jbc. M707000200.
22. Risbud MV, Shapiro IM, Guttapalli A, Di Martino A, Danielson KG, Beiner JM, Hillibrand A, Albert TJ, Anderson DG, Vaccaro AR (2006) Osteogenic potential of adult human stem cells of the lumbar vertebral body and the iliac crest. Spine (Phila Pa 1976) 31: 83-89. doi: 00007632-200601010-00019.
23. Rustemeyer J, Bremerich A (2009) Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature. Clin Oral Investig 14: 59-64. doi: 10. 1007/s00784-009-0294-0.
24. Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T (2010) Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Investig 14(1): 35-41. doi: 10. 1007/s00784-009-0266-4.
25. Koch FP, Merkel C, Ziebart T, Smeets R, Walter C, Al-Nawas B (2010) Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. Clin Oral Investig. doi: 10. 1007/s00784-010-0477-8.
26. Stanley Er Fau-Berg KL, Berg Kl Fau-Einstein DB, Einstein Db Fau-Lee PS, Lee Ps Fau-Pixley FJ, Pixley Fj Fau-Wang Y, Wang Y Fau-Yeung YG, Yeung YG (1997) Biology and action of colony-stimulating factor-1. Mol Reprod Dev 46: 4-10.
27. Boyce BF, Xing L (2008) Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473: 139-146.
28. Rogers MJ (2003) New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 9: 2643-2658.